Federal agencies have been branding some of their research and policy work as “gold standard science,” a trend that gained new force after an executive order on the term was issued in May 2025. The phrase now appears in speeches and guidance documents from agencies such as the National Science Foundation and the National Institutes of Health. It shows up in social media posts intended to signal credibility, rigor, and authority. The message is clear: This is science you can trust.

The intention may be to reassure the public, but the framing is misleading. The executive order outlines principles that are broadly consistent with good scientific practice, such as transparency, reproducibility, and peer review. These are not controversial. The problem arises in how those principles are translated into a simplified label that suggests a single hierarchy of evidence.

In scientific practice, “gold standard” has never meant universally best. It has always been conditional. Researchers have used the phrase to describe the most appropriate method for answering a very specific type of question, under particular assumptions and constraints. Outside of that narrow context, the phrase loses its meaning.

One of the most common examples comes from medicine. Randomized controlled trials are often described as the gold standard for determining whether a drug or clinical intervention causes a particular outcome. The reason is straightforward. Randomization helps isolate cause and effect by reducing bias and confounding. When the question is whether treatment A is superior to treatment B under controlled conditions, randomized trials can be extraordinarily powerful.